US: APNHY - Aspen Pharmacare Holdings Ltd ADR

Yield per half year: -30.62%
Dividend yield: 1.79%

Share chart Aspen Pharmacare Holdings Ltd ADR

Extended chart Simple chart
Financial Markets by TradingView

About Aspen Pharmacare Holdings Ltd ADR

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names.

more details
It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN US04530Y1064
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета zar
Див.доход ао 1.79
Дивиденд ао 0.2
Сайт https://www.aspenpharma.com
Цена ао 6.86
Change price per day: -0.3035% (6.59)
Change price per week: -2.81% (6.76)
Change price per month: -21.03% (8.32)
Change price per 3 month: -29.35% (9.3)
Change price per half year: -30.62% (9.47)
Change price per year: -41.18% (11.169)
Change price per 3 year: -53.27% (14.058)
Change price per 5 year: +1.78% (6.455)
Change price per year to date: -29.96% (9.38)
All parameters

Underestimation

Title Value Grade
P/S 2.31 6
P/BV 1.22 9
P/E 23.42 6
EV/EBITDA 12.85 7
Total: 5.75

Efficiency

Title Value Grade
ROA, % 3.22 1
ROE, % 5.15 2
Total: 2.67

Dividends

Title Value Grade
Div yield, % 1.79 4.48
DSI 0.9286 9.29
Total: 6.18

Debt

Title Value Grade
Debt/EBITDA 3.68 3
Total: 5.6

Growth impulse

Title Value Grade
Yield Revenue, % 1980.93 10
Yield Ebitda, % 1589.72 10
Yield EPS, % 1954.38 10
Total: 9.8
More

Head Job title Payment Year of birth
Mr. Stephen Bradley Saad BCom, CA(SA) Group CEO & Executive Director 1964 (61 year)
Mr. Sean M. Capazorio Group CFO & Executive Director 1967 (58 years)
Ms. Lorraine Hill Group Chief Operations Officer & Responsible Pharmacist 1964 (61 year)
Mr. Michael Guy Attridge B.Com., CA(SA) Group Chief Advisor 1961 (64 years)
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA Group Chief Corporate Services Officer & Executive Director 1975 (50 years)
Ms. Zizipho Mmango Group Chief Strategic Development Officer 1985 (40 years)
Sibongakonke Nkosi Investor Relations Manager
Mr. Trevor Julian Ziman Regional Chief Executive Officer of Asia Pacific 1972 (53 years)
Mr. Samer Kassem Chief Executive Officer of Aspen Global Incorporated 1975 (50 years)
Ms. Raeesa Khan Group Company Secretary

Address: South Africa, Durban, Aspen Place - open in Google maps, open in Yandex maps
Website: https://www.aspenpharma.com